In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir

Telaprevir is a linear, peptidomimetic small molecule that inhibits hepatitis C virus (HCV) replication by specifically inhibiting the NS3·4A protease. In phase 3 clinical studies, telaprevir in combination with peginterferon and ribavirin (PR) significantly improved sustained virologic response (SV...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jiang, Min, Mani, Nagraj, Lin, Chao, Ardzinski, Andrzej, Nelson, Michelle, Reagan, Dugan, Bartels, Doug, Zhou, Yi, Nicolas, Olivier, Rao, B. Govinda, Müh, Ute, Hanzelka, Brian, Tigges, Ann, Rijnbrand, Rene, Kieffer, Tara L.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837892/
https://ncbi.nlm.nih.gov/pubmed/24100495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01578-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars